Posted On: 01/12/2015 9:58:12 AM
Post# of 30066
Re: biotechexpert #14779
Quote:Read the news release. As a ballpark estimate, $8M / 0.08 share price = 100M shares max. Sale of the $7.45M New Jersey tax credit at a minimum 75% of value will generate $5.6M or higher to offset the $8M acquisition price.
How is AMBS paying for this? Maybe 300-500 million shares that were just authorized?
Not too bad, and certainly far from the 300-500 million share range you suggested. But we really won't know until Gerald reveals more in his blog or when we see the filings for the actual transaction. All considered, looks like a very lucrative addition to the company's diagnostic assets.
(0)
(0)
